2013 General Call for Research Proposals
The Angelman Syndrome Foundation announces the availability of up to $1,000,000 (USD) to be awarded in support of research on Angelman syndrome.
Angelman syndrome is a neurodevelopmental disorder caused by deficiency of the ubiquitin protein ligase UBE3A in the brain. Applications in the preclinical, translational and clinical research areas that investigate all aspects of Angelman syndrome will be considered. Highest priority will be given to pilot projects to test new ideas about pathogenesis and therapeutics of Angelman syndrome. Researchers from all countries are encouraged to apply.
One- or two-year grants will be awarded for amounts ranging from $10,000 to $100,000 per year. The application should include the following:
- Cover letter with title of proposal and name of principal investigator
- One-page summary abstract of proposed research
- Proposal, including hypothesis, background, research plan, and significance of the proposed research (see downloadable application for specific lengths for each section).
- One-page detailed budget (one page budget per year if two-year proposal)
- Curriculum vitae of the applicant
- Indirect costs of up to 10% will be allowed (to be included in the budget amount)
- Proposals involving human or animal subjects must be approved by institutional review boards before funding is released. Please include approval with proposal if possible.
The application deadline is April 12, 2013. All proposals, including cover letters, are to be submitted electronically using the ASF Grant Submission Form, which may be downloaded here.
Subject line to read: ASF 2013 General RFP Submission.
File name to read: Researcher last name_2013_Gen_RFP.pdf.
Questions about this announcement should be directed to Daniel F. Harvey, Ph.D. via ASF at: research@angelman.org.
Please forward this information to others within your institution or to those interested in conducting Angelman syndrome research.